SCHEMBL25049059

SCHEMBL25049059

c1ccc2cc3c(cc2c1)c1cc2ccccc2cc1n3-c1cc2c(cc1-c1nc(-c3cccc4ccccc34)nc(-c3cccc4ccccc34)n1)oc1ccc3ccccc3c12

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.34
ALDH1A1 P00352 3/20 0.34
MEN1 O00255 2/20 0.34
KMT2A Q03164 2/20 0.34
HPGD P15428 2/20 0.34
HSD17B10 Q99714 2/20 0.34
NPC1 O15118 1/20 0.34
RAB9A P51151 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
AHR P35869 5/20 0.34
TP53 P04637 1/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2D6 P10635 1/20 0.34
CYP2C9 P11712 1/20 0.34
CYP2C19 P33261 1/20 0.34
PRKDC P78527 1/20 0.33
ESR1 P03372 1/20 0.32
ESR2 Q92731 1/20 0.32
MAOA P21397 1/20 0.32
MAOB P27338 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25051102 0.91 MEN1 (0.31) MAPTALDH1A1MEN1KMT2AHPGD
SCHEMBL25049049 0.90 CYP1A1 (0.33) MAPTALDH1A1HPGDHSD17B10NPC1
SCHEMBL23738825 0.90 L3MBTL1 (0.33) MAPTMEN1KMT2ANPC1RAB9A
SCHEMBL23738350 0.88 ABCG2 (0.36) MAPTALDH1A1KMT2AHPGDHSD17B10
SCHEMBL24382647 0.88
SCHEMBL24382442 0.88 CYP1A1 (0.33) MAPTALDH1A1HPGDHSD17B10L3MBTL1
SCHEMBL23737935 0.87 ABCG2 (0.36) MAPTALDH1A1KMT2AHPGDHSD17B10
SCHEMBL23737131 0.86 CHEK2 (0.35) MAPTALDH1A1MEN1KMT2AHPGD
SCHEMBL23203644 0.85 AHR (0.33) MAPTALDH1A1MEN1KMT2AHPGD
SCHEMBL23738219 0.85 AHR (0.35) MAPTALDH1A1MEN1KMT2AHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230049674-A1 ORGANIC LIGHT EMITTING DEVICE LG CHEM, LTD. (KR) 2023-02-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230049674-A1 ORGANIC LIGHT EMITTING DEVICE CRY2, ELOVL1, CRY1 MAPT 1921/4885ALDH1A1 29/4885MEN1 1547/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.